Profile
Dr. Yariv J.
Houvras is a Chief Medical Officer at Xilio Therapeutics, Inc. Dr. Houvras was previously employed as a SVP-Clinical & Translational Development by Tubulis GmbH.
He received his undergraduate degree from the University of Michigan and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Yariv Houvras active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/09/2026 |
Former positions of Yariv Houvras
| Companies | Position | End |
|---|---|---|
Tubulis GmbH
Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors | Corporate Officer/Principal | - |
Training of Yariv Houvras
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Tubulis GmbH
Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors | Health Technology |
- Stock Market
- Insiders
- Yariv Houvras
















